1. Home
  2. MRNA vs CCK Comparison

MRNA vs CCK Comparison

Compare MRNA & CCK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRNA
  • CCK
  • Stock Information
  • Founded
  • MRNA 2010
  • CCK 1906
  • Country
  • MRNA United States
  • CCK United States
  • Employees
  • MRNA N/A
  • CCK N/A
  • Industry
  • MRNA Biotechnology: Biological Products (No Diagnostic Substances)
  • CCK Containers/Packaging
  • Sector
  • MRNA Health Care
  • CCK Industrials
  • Exchange
  • MRNA Nasdaq
  • CCK Nasdaq
  • Market Cap
  • MRNA 13.4B
  • CCK 12.1B
  • IPO Year
  • MRNA 2018
  • CCK N/A
  • Fundamental
  • Price
  • MRNA $34.15
  • CCK $102.96
  • Analyst Decision
  • MRNA Hold
  • CCK Buy
  • Analyst Count
  • MRNA 20
  • CCK 13
  • Target Price
  • MRNA $46.76
  • CCK $121.23
  • AVG Volume (30 Days)
  • MRNA 9.4M
  • CCK 1.2M
  • Earning Date
  • MRNA 08-01-2025
  • CCK 07-21-2025
  • Dividend Yield
  • MRNA N/A
  • CCK 1.01%
  • EPS Growth
  • MRNA N/A
  • CCK 31.01
  • EPS
  • MRNA N/A
  • CCK 4.73
  • Revenue
  • MRNA $3,177,000,000.00
  • CCK $12,013,000,000.00
  • Revenue This Year
  • MRNA N/A
  • CCK $3.47
  • Revenue Next Year
  • MRNA $9.70
  • CCK $2.51
  • P/E Ratio
  • MRNA N/A
  • CCK $21.77
  • Revenue Growth
  • MRNA N/A
  • CCK 2.23
  • 52 Week Low
  • MRNA $23.15
  • CCK $75.98
  • 52 Week High
  • MRNA $125.68
  • CCK $109.48
  • Technical
  • Relative Strength Index (RSI)
  • MRNA 64.57
  • CCK 42.05
  • Support Level
  • MRNA $30.88
  • CCK $105.01
  • Resistance Level
  • MRNA $35.59
  • CCK $106.87
  • Average True Range (ATR)
  • MRNA 1.48
  • CCK 2.11
  • MACD
  • MRNA 0.11
  • CCK -0.69
  • Stochastic Oscillator
  • MRNA 74.05
  • CCK 9.07

About MRNA Moderna Inc.

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

About CCK Crown Holdings Inc.

Crown Holdings is one of the world's largest producers of metal packaging. The company manufactures beverage cans, metal food cans, and closures as well as aerosol cans. With the purchase of Signode, the company also has a presence in a wide variety of protective transport packaging. Although it's headquartered in the United States, the vast majority of Crown's sales come from its operations in Europe, South America, and Southeast Asia.

Share on Social Networks: